Choreo LLC Invests $320,000 in STERIS plc (NYSE:STE)

Choreo LLC acquired a new position in shares of STERIS plc (NYSE:STE) in the fourth quarter, Holdings Channel.com reports. The fund acquired 1,457 shares of the medical equipment provider’s stock, valued at approximately $320,000.

Several other hedge funds and other institutional investors also recently added to or reduced their stakes in STE. Greenleaf Trust grew its position in STERIS by 2.8% during the third quarter. Greenleaf Trust now owns 1,888 shares of the medical equipment provider’s stock valued at $414,000 after acquiring an additional 51 shares during the last quarter. Park Edge Advisors LLC grew its holdings in shares of STERIS by 1.2% during the 4th quarter. Park Edge Advisors LLC now owns 4,409 shares of the medical equipment provider’s stock valued at $969,000 after purchasing an additional 51 shares during the last quarter. UMB Bank n.a. raised its position in STERIS by 7.8% in the 4th quarter. UMB Bank n.a. now owns 716 shares of the medical equipment provider’s stock worth $157,000 after purchasing an additional 52 shares during the period. Sumitomo Mitsui DS Asset Management Company Ltd raised its position in STERIS by 0.6% in the 3rd quarter. Sumitomo Mitsui DS Asset Management Company Ltd now owns 8,944 shares of the medical equipment provider’s stock worth $1,962,000 after purchasing an additional 54 shares during the period. Finally, Legacy Wealth Asset Management LLC lifted its stake in STERIS by 1.5% in the fourth quarter. Legacy Wealth Asset Management LLC now owns 3,544 shares of the medical equipment provider’s stock worth $779,000 after purchasing an additional 54 shares during the last quarter. 94.69% of the stock is currently owned by hedge funds and other institutional investors.

STERIS Price Performance

Shares of STE stock opened at $207.82 on Friday. The company has a debt-to-equity ratio of 0.50, a quick ratio of 1.49 and a current ratio of 2.43. The firm has a market cap of $20.53 billion, a P/E ratio of 36.40 and a beta of 0.81. The business’s 50 day moving average price is $218.46 and its 200-day moving average price is $216.18. STERIS plc has a fifty-two week low of $185.22 and a fifty-two week high of $254.00.

STERIS (NYSE:STE) last released its quarterly earnings results on Wednesday, February 7th. The medical equipment provider reported $2.22 earnings per share for the quarter, beating the consensus estimate of $2.17 by $0.05. STERIS had a net margin of 10.48% and a return on equity of 13.67%. The business had revenue of $1.40 billion for the quarter, compared to analysts’ expectations of $1.35 billion. During the same quarter in the previous year, the business posted $2.02 earnings per share. The firm’s revenue for the quarter was up 14.8% compared to the same quarter last year. On average, equities research analysts anticipate that STERIS plc will post 8.67 earnings per share for the current year.

STERIS Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Wednesday, June 26th. Investors of record on Wednesday, June 12th will be paid a $0.52 dividend. This represents a $2.08 dividend on an annualized basis and a yield of 1.00%. The ex-dividend date is Wednesday, June 12th. STERIS’s payout ratio is currently 36.43%.

Analyst Upgrades and Downgrades

A number of research analysts have recently issued reports on the company. TheStreet raised STERIS from a “c+” rating to a “b” rating in a research note on Wednesday, February 7th. Stephens restated an “overweight” rating and set a $250.00 price target on shares of STERIS in a research report on Friday, February 9th. StockNews.com downgraded STERIS from a “buy” rating to a “hold” rating in a research report on Friday. KeyCorp initiated coverage on shares of STERIS in a report on Tuesday, February 6th. They issued an “overweight” rating and a $253.00 target price on the stock. Finally, Needham & Company LLC reiterated a “hold” rating on shares of STERIS in a report on Friday, April 12th. Four investment analysts have rated the stock with a hold rating and three have given a buy rating to the stock. According to MarketBeat.com, the stock currently has an average rating of “Hold” and an average target price of $239.60.

STERIS Profile

STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services.